Hollencrest Capital Management Eli Lilly & CO Transaction History

Hollencrest Capital Management

$2.17 Billion
Q1 2024

A detailed history of Hollencrest Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Hollencrest Capital Management holds 1,490 shares of LLY stock, worth $1.35 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,490

Previous 3,381 55.93%

Holding current value

$1.35 Million

Previous $1.97 Million 41.17%

% of portfolio

0.05%

Previous 0.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$592.2 - $792.28 $1.12 Million - $1.5 Million	-1,891 Reduced 55.93%	1,490 $1.16 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $27,835 - $32,813	53 Added 1.59%	3,381 $1.97 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1,738 - $2,397	-4 Reduced 0.12%	3,328 $1.79 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $2,805 - $3,751	8 Added 0.24%	3,332 $1.56 Million
Q1 2023 May 16, 2023	BUY	$310.63 - $364.82 $380,211 - $446,539	1,224 Added 58.29%	3,324 $1.14 Million

Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $339,556 - $395,651	1,056 Added 101.15%	2,100 $768,000
Q3 2022 Oct 27, 2022	BUY	$296.48 - $337.87 $32,909 - $37,503	111 Added 11.9%	1,044 $338,000
Q2 2022 Jul 21, 2022	BUY	$278.73 - $327.27 $19,511 - $22,908	70 Added 8.11%	933 $302,000
Q1 2022 Apr 18, 2022	BUY	$234.69 - $291.66 $4,693 - $5,833	20 Added 2.37%	863 $247,000
Q4 2021 Jan 07, 2022	BUY	$224.85 - $279.04 $189,548 - $235,230	843 New	843 $233,000
Q2 2021 Jul 21, 2021	SELL	$180.55 - $233.54 $297,726 - $385,107	-1,649 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $4,272 - $5,530	-26 Reduced 1.55%	1,649 $308,000
Q3 2020 Oct 13, 2020	SELL	$146.22 - $169.13 $1,462 - $1,691	-10 Reduced 0.59%	1,675 $248,000
Q2 2020 Jul 16, 2020	BUY	$136.42 - $164.18 $229,867 - $276,643	1,685 New	1,685 $277,000
Q2 2019 Jul 18, 2019	SELL	$110.79 - $129.32 $670,390 - $782,515	-6,051 Closed	0 $0
Q4 2017 Jan 19, 2018	BUY	$81.94 - $87.89 $180,268 - $193,358	2,200 Added 57.13%	6,051 $0
Q3 2017 Oct 10, 2017	BUY	$77.07 - $85.54 $296,796 - $329,414	3,851	3,851 $329,000

Others Institutions Holding LLY

# of Institutions

3,721

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $862B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Eli Lilly & CO Transaction History